HUMAW - Humacyte GAAP EPS of -$0.24 in-line March, 22 2024 07:20 AM Humacyte Inc. Warrant 2024-03-22 07:20:05 ET More on Humacyte Humacyte stock dips after pricing stock offering to raise $40.2M Humacyte gains on FDA priority review for bioengineered blood vessel Seeking Alpha’s Quant Rating on Humacyte Historical earnings data for Humacyte Financial information for Humacyte For further details see: Humacyte GAAP EPS of -$0.24 in-line